Trump Administration Weighs Marijuana Rescheduling as Lawmaker Reintroduces Bill

President Donald Trump confirmed Monday that his administration is weighing whether to reclassify marijuana as a less dangerous drug, potentially reducing criminal penalties and providing significant tax relief to cannabis companies.

Speaking during a White House press conference, Trump said the administration will “make a determination over, I’d say, the next few weeks” on whether to move marijuana from Schedule I to Schedule III under the Controlled Substances Act.

Rep. Greg Steube, R-Fla., announced this week he is reintroducing his Marijuana 1-to-3 Act, which would accomplish the same reclassification through congressional action. Steube called the current system illogical, noting that marijuana is classified alongside heroin and LSD while cocaine receives a less restrictive Schedule II designation.

“This is a common-sense change that will finally allow real scientific research into its medicinal value,” Steube said, urging the Trump administration to support the effort.

Under federal law, marijuana is currently a Schedule I substance, defined as having “no currently accepted medical use and a high potential for abuse.” Schedule III drugs, by contrast, are considered to have “moderate to low risk of physical or psychological dependence” and include ketamine, anabolic steroids and certain prescription medications.

Related: Is Trump Moving Forward with Marijuana Rescheduling? 

The reclassification would not make marijuana federally legal for recreational use, but would significantly benefit the cannabis industry. Companies would no longer be subject to Section 280E of the federal tax code, which prevents businesses dealing with Schedule I and II controlled substances from claiming standard business deductions.

The push comes after cannabis industry executives attended a $1 million-per-plate fundraiser at Trump’s New Jersey golf club earlier this month, where they discussed potential policy changes with the president. 

Related: DEA Nominee Views Cannabis Reclassification as Priority, Stops Short of Guarantee

Tilray CEO Irwin Simon told CNBC he expects the reclassification process to take about a year if implemented. “Trump gets things done,” Simon said. “He wouldn’t be talking about it if he’s not going to get something done.”



Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Silver47 Samples 44.5 g/t Gold, 3,037 g/t Silver & 8.56% Copper At Kennedy Project In Nevada

Related News

Trump’s Pro-Marijuana Campaign Promises Fade as Rescheduling Stalls

President Donald Trump campaigned on supporting marijuana reform, making history as the first major party...

Friday, May 23, 2025, 12:52:00 PM

US, Saudi Ink $600B Megadeals With Defense, Mining, and Energy at the Core

The US and Saudi Arabia signed a sweeping set of agreements this week spanning energy,...

Saturday, May 17, 2025, 01:19:00 PM

Trump Renews Push to Privatize Fannie Mae, Freddie Mac

President Donald Trump confirmed this week he plans to privatize Fannie Mae and Freddie Mac,...

Thursday, May 29, 2025, 12:53:00 PM

House Democrats Seek to Restrict Trump’s Ability to Take Military Action Against Neighboring Nations

A Democratic lawmaker has introduced legislation that would prohibit the use of US military funds...

Monday, March 10, 2025, 12:56:00 PM

CDC ‘Being Ripped Apart,’ Trump Says in First Response

President Donald Trump demanded Monday that drug manufacturers publicly prove their COVID-19 vaccines are effective,...

Tuesday, September 2, 2025, 02:57:00 PM